OTCMKTS:HLUYY H. Lundbeck A/S - HLUYY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding H. Lundbeck A/S Please log in to your account or sign up in order to add this asset to your watchlist. $22.00 -0.01 (-0.02%) (As of 08/9/2022) Add Compare Share Share Today's Range$22.00▼$24.0050-Day Range$22.00▼$22.0052-Week Range$10.00▼$31.55Volume7,500 shsAverage Volume1,758 shsMarket Capitalization$21.91 billionP/E Ratio25.00Dividend Yield0.91%Price Target$36.50 ProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesShort Interest About H. Lundbeck A/S (OTCMKTS:HLUYY) StockH. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.Read More Receive HLUYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address HLUYY Stock News HeadlinesFebruary 8, 2023 | msn.comH. Lundbeck A/S reports FY resultsNovember 24, 2022 | finance.yahoo.comH. Lundbeck A/S (HLUN-B.CO)March 22, 2023 | PressReach (Ad)Stocks Positioned For The YearThis breakthrough stock has bright future this decade.October 20, 2022 | investing.comH Lundbeck B (HLUNb)September 14, 2022 | msn.comMonica Lewinsky's Response to Death of Clinton Prosecutor Ken Starr PraisedSeptember 13, 2022 | msn.comWatch Lucid's Boss Spend an Hour Explaining How the Air's Motor WorksSeptember 9, 2022 | msn.comEveryone's Saying The Same Thing About Odell Beckham Jr. TonightSeptember 6, 2022 | msn.comSlain Memphis jogger Eliza Fletcher was a 2010 graduate of Baylor UniversityMarch 22, 2023 | PressReach (Ad)Stocks Positioned For The YearThis breakthrough stock has bright future this decade.September 3, 2022 | msn.comFormer Lutz Children’s Museum director busted on child pornography chargesSeptember 2, 2022 | msn.comFormer executive director for Manchester children's museum pleads guilty to distributing child pornographyAugust 31, 2022 | finance.yahoo.comRuben Östlund Remembers ‘Triangle of Sadness’ Actress Charlbi Dean: ‘A Shock and a Tragedy’June 25, 2022 | businessinsider.comEV startup Lucid froze its assembly line for a week in early June amid its ongoing struggle to ramp up productionJune 17, 2022 | finance.yahoo.comH Lundbeck AS (HLUYY) Surges 12.5%: Is This an Indication of Further Gains?June 13, 2022 | msn.comPolice: Rollover crash leads to drunk driving charge for Hudson, N.H. womanJune 11, 2022 | msn.comDenmark and Leipzig's Poulsen suffers fifth muscle pull of seasonFebruary 16, 2022 | ca.finance.yahoo.comMental Health America Releases First-Ever Dashboard With Results of 2.6 Million Mental Health Screens Taken During PandemicJanuary 24, 2022 | nasdaq.comH. Lundbeck AS ADR (HLUYY)October 13, 2021 | benzinga.comNew Analysis Finds St. Louis County, Missouri Had...August 26, 2021 | barrons.comH. Lundbeck A/S ADRAugust 19, 2021 | seekingalpha.comH. Lundbeck A/S 2021 Q2 - Results - Earnings Call PresentationAugust 18, 2021 | markets.businessinsider.comH Lundbeck A-S (spons ADRs) is about to announce its earnings — here's what to expectJuly 14, 2021 | markets.businessinsider.comGlobal Generic Drugs Market to Reach $507.8 Billion by 2026July 6, 2021 | marketwatch.comNeuroscience Market by Latest Trend, Growing Demand and Technology Advancement 2021-2027July 5, 2021 | marketwatch.comGlobal Depression Therapeutics Market Size, Share and Analysis to Account for USD 14700 million By 2025July 2, 2021 | finance.yahoo.comLundbeck Out Licenses Flopped Alzheimer's Drug In Wake Of Biogen's Controversial Success With AducanumabJune 26, 2021 | marketwatch.comDepression Treatment Market Top Players, Size, Business Scenario, Share, Growth, Insights, Industry Analysis, Trends and Forecasts Report 2027See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HLUYY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address HLUYY Company Calendar Last Earnings11/04/2015Today3/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private Households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:HLUYY CUSIPN/A CIKN/A Webwww.lundbeck.com Phone(453) 630-1311Fax45-3630-1940Employees5,348Year Founded1915Price Target and Rating Average Stock Price Forecast$36.50 High Stock Price Forecast$44.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+65.9%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.88 Trailing P/E Ratio25.00 Forward P/E Ratio10.48 P/E GrowthN/ANet Income$209.69 million Net Margins6.74% Pretax Margin7.83% Return on Equity13.74% Return on Assets7.16% Debt Debt-to-Equity Ratio0.32 Current Ratio1.15 Quick Ratio0.71 Sales & Book Value Annual Sales$2.59 billion Price / Sales8.45 Cash Flow$3.36 per share Price / Cash Flow6.54 Book Value$14.60 per share Price / Book1.51Miscellaneous Outstanding Shares995,741,000Free FloatN/AMarket Cap$21.91 billion OptionableNot Optionable Beta0.68 Social Links Key ExecutivesDr. Deborah Dunsire M.D. (Age 60)Pres & CEO Comp: $7.16MMr. Jacob Tolstrup (Age 50)Exec. VP of Commercial Operations & Chief Commercial Officer Comp: $888.17kMr. Lars Bang (Age 60)Exec. VP of Product Devel. & Supply Comp: $915.5kDr. Per Johan Luthman (Age 63)Exec. VP of R&D Comp: $901.84kMr. Bjorn R. MogensenSr. VP Group Fin.Dr. Tarek Samad Ph.D.Sr. VP & Head of ResearchMr. Palle Holm OlesenChief Specialist & VP of Investor RelationsMs. Elise Hauge (Age 55)Exec. VP of People & Communication Mr. Ole Chrintz (Age 64)Sr. VP of International Markets Mr. Keld Flintholm Jorgensen (Age 51)Exec. VP of Corp. Strategy & Bus. Devel. More ExecutivesKey CompetitorsEisaiOTCMKTS:ESALYShionogi & Co., Ltd.OTCMKTS:SGIOYSysmexOTCMKTS:SSMXYSunny Optical Technology (Group)OTCMKTS:SNPTFEurofins ScientificOTCMKTS:ERFSFView All Competitors HLUYY Stock - Frequently Asked Questions Should I buy or sell H. Lundbeck A/S stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for H. Lundbeck A/S in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLUYY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLUYY, but not buy additional shares or sell existing shares. View HLUYY analyst ratings or view top-rated stocks. What is H. Lundbeck A/S's stock price forecast for 2023? 5 Wall Street research analysts have issued 12 month price targets for H. Lundbeck A/S's shares. Their HLUYY share price forecasts range from $28.00 to $44.00. On average, they expect the company's stock price to reach $36.50 in the next twelve months. This suggests a possible upside of 65.9% from the stock's current price. View analysts price targets for HLUYY or view top-rated stocks among Wall Street analysts. How have HLUYY shares performed in 2023? H. Lundbeck A/S's stock was trading at $22.00 at the start of the year. Since then, HLUYY shares have increased by 0.0% and is now trading at $22.00. View the best growth stocks for 2023 here. How were H. Lundbeck A/S's earnings last quarter? H. Lundbeck A/S (OTCMKTS:HLUYY) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.16. The firm earned $547.05 million during the quarter, compared to analyst estimates of $514.82 million. H. Lundbeck A/S had a net margin of 6.74% and a trailing twelve-month return on equity of 13.74%. Is H. Lundbeck A/S a good dividend stock? H. Lundbeck A/S (OTCMKTS:HLUYY) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.91%. The dividend payout ratio is 22.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLUYY will have a dividend payout ratio of 7.02% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for HLUYY. What is H. Lundbeck A/S's stock symbol? H. Lundbeck A/S trades on the OTCMKTS under the ticker symbol "HLUYY." How do I buy shares of H. Lundbeck A/S? Shares of HLUYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is H. Lundbeck A/S's stock price today? One share of HLUYY stock can currently be purchased for approximately $22.00. How much money does H. Lundbeck A/S make? H. Lundbeck A/S (OTCMKTS:HLUYY) has a market capitalization of $21.91 billion and generates $2.59 billion in revenue each year. The company earns $209.69 million in net income (profit) each year or $0.88 on an earnings per share basis. How many employees does H. Lundbeck A/S have? The company employs 5,348 workers across the globe. Does H. Lundbeck A/S have any subsidiaries? The following companies are subsidiares of H. Lundbeck A/S: Alder BioPharmaceuticals, and Prexton Therapeutics.Read More How can I contact H. Lundbeck A/S? H. Lundbeck A/S's mailing address is Ottiliavej 9 Valby, Copenhagen G7, 2500. The official website for the company is www.lundbeck.com. The company can be reached via phone at (453) 630-1311, via email at palo@lundbeck.com, or via fax at 45-3630-1940. This page (OTCMKTS:HLUYY) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.